Literature DB >> 12088775

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Frank Grothues1, Gillian C Smith, James C C Moon, Nicholas G Bellenger, Peter Collins, Helmut U Klein, Dudley J Pennell.   

Abstract

Fast breath-hold cardiovascular magnetic resonance (CMR) shows excellent results for interstudy reproducibility of left ventricular (LV) volumes, ejection fraction, and mass, which are thought to be superior to results of 2-dimensional echocardiography. However, there is no direct comparison of the interstudy reproducibility of both methods in the same subjects. A total of 60 subjects (normal volunteers [n = 20], or patients with heart failure [n = 20] or LV hypertrophy [n = 20]) underwent 2 CMRs and 2 echocardiographic studies for assessment of LV volumes, function, and mass. The interstudy reproducibility coefficient of variability was superior for CMR in all groups for all parameters. Statistical significance was reached for end-systolic volume (4.4% to 9.2% vs 13.7% to 20.3%, p <0.001), ejection fraction (2.4% to 7.3% vs 8.6% to 19.4%, p <0.001), and mass (2.8% to 4.8% vs 11.6% to 15.7% p <0.001), with a trend for end-diastolic volume (2.9% to 4.9% vs 5.5% to 10.5%, p = 0.17). The superior interstudy reproducibility resulted in considerably lower calculated sample sizes (reductions of 55% to 93%) required by CMR compared with echocardiography to show clinically relevant changes in LV dimensions and function. Thus, CMR has excellent interstudy reproducibility in normal, dilated, and hypertrophic hearts, and is superior to 2-dimensional echocardiography.

Entities:  

Mesh:

Year:  2002        PMID: 12088775     DOI: 10.1016/s0002-9149(02)02381-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  417 in total

1.  Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.

Authors:  Petri Sipola; Jarkko Magga; Minna Husso; Pertti Jääskeläinen; Keijo Peuhkurinen; Johanna Kuusisto
Journal:  Eur Radiol       Date:  2011-01-28       Impact factor: 5.315

2.  Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.

Authors:  Jeong Rang Park; Jin-Oh Choi; Hye Jin Han; Sung-A Chang; Sung-Ji Park; Sang-Chol Lee; Yeon Hyeon Choe; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2011-04-24       Impact factor: 2.357

Review 3.  Assessment of ventricular function and mass by cardiac magnetic resonance imaging.

Authors:  Khaled Alfakih; Scott Reid; Tim Jones; Mohan Sivananthan
Journal:  Eur Radiol       Date:  2004-07-17       Impact factor: 5.315

Review 4.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

5.  Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults.

Authors:  André La Gerche; Andrew T Burns; Andrew J Taylor; Andrew I Macisaac; Hein Heidbüchel; David L Prior
Journal:  Eur J Appl Physiol       Date:  2011-10-01       Impact factor: 3.078

6.  Quantitative analysis of cardiac left ventricular variables obtained by MRI at 3 T: a pre- and post-contrast comparison.

Authors:  S Matthew; S J Gandy; R S Nicholas; S A Waugh; E A Crowe; R A Lerski; M H Dunn; J G Houston
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

7.  [Cardiac functional analysis with MRI].

Authors:  T A Sandner; D Theisen; K U Bauner; M Picciolo; M F Reiser; B J Wintersperger
Journal:  Radiologe       Date:  2010-06       Impact factor: 0.635

8.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 9.  Valvular heart disease: what does cardiovascular MRI add?

Authors:  Pier Giorgio Masci; Steven Dymarkowski; Jan Bogaert
Journal:  Eur Radiol       Date:  2007-08-29       Impact factor: 5.315

10.  Self-gated MRI of multiple beat morphologies in the presence of arrhythmias.

Authors:  Francisco Contijoch; Srikant Kamesh Iyer; James J Pilla; Paul Yushkevich; Joseph H Gorman; Robert C Gorman; Harold Litt; Yuchi Han; Walter R T Witschey
Journal:  Magn Reson Med       Date:  2016-08-31       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.